Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
15 Maggio 2023 - 1:31PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934
For the month of May 2023
Commission
File Number 001- 41291
Meihua
International Medical Technologies Co., Ltd.
(Translation of registrant’s name into English)
88 Tongda Road, Touqiao Town
Guangling District, Yangzhou, 225000
People’s Republic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:
Form 20-F ☒
Form 40-F ☐
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
Meihua International Medical Technologies
Co., Ltd. |
|
|
Dated: May 15, 2023 |
By: |
/s/ Xin Wang |
|
Name: |
Xin Wang |
|
Title: |
Chief Executive Officer |
2
Grafico Azioni Meihua International Med... (NASDAQ:MHUA)
Storico
Da Feb 2025 a Mar 2025
Grafico Azioni Meihua International Med... (NASDAQ:MHUA)
Storico
Da Mar 2024 a Mar 2025